Mike Baum

2.8k citations
27 papers · 2.4k · 1 hit paper · h-index 10

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Cancer Risks and Factors
    • Global Cancer Incidence and Screening

Papers in

    • Global Cancer Incidence and Screening 3
    • Cancer Risks and Factors 2
    • Cancer survivorship and care 2
    • Breast Cancer Treatment Studies 6

Mike Baum

25 papers receiving 2.3k citations

Mike Baum's Hit Papers

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. 1998 · 1.9k citations
1.9k0+9+18Years since publication50010001.5k

Peers

Mike Baum
Comparison fields: 5 of 89
  • Cancer Research 1.0k
  • Oncology 1.0k
  • Genetics 820
  • Reproductive Medicine 80
  • Obstetrics and Gynecology 65
Replace Olugbenga Emmanuel Abe with:
Olugbenga Emmanuel Abe Japan
Nicola Scorpiglione Italy
J. L. Hayward United Kingdom
Riva Borovik Israel
Masaru Izuo Japan
Ingrid Tengrup Sweden
JE Varhaug Norway
JB Vermorken Netherlands
R Abe Japan
B Carstensen Denmark
Mike Baum relative to Olugbenga Emmanuel Abe Japan Olugbenga Emmanuel Abe's profile →
Citations per field
00.5×2×3×3.7×
Olugbenga Emmanuel Abe · 1×
Citations per year

Countries citing papers authored by Mike Baum

Since Specialization
Citations

This map shows the geographic impact of Mike Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Baum more than expected).

Fields of papers citing papers by Mike Baum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Baum. The network helps show where Mike Baum may publish in the future.

Co-authors

The 25 scholars most cited alongside Mike Baum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mike Baum Line = papers co-authored together Mike Baum links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Hit paper breakdown →
19981919
2 1994131
3 199084
4 200679
5 200058
6
Using an interactive video disk in breast cancer patient support.
199925
7 200221
8 200418
9 200117
10 199316
11
Delay in presentation of women with breast disease.
197610
12 19988
13
Management of premenopausal women with early breast cancer. Is there a role for Goserelin?
20018
14
Proceedings: macrophage phagocytic activity in patients with breast cancer.
19737
15 19985
16 19754
17
Is there a role for perioperative adjuvant therapy in the treatment of early breast cancer?
19882
18
Treatment of early breast cancer: the organization of a 'national trial'.
19712
19 20072
20
Depression of delayed hypersensitivity and abnormal bone scans in early cancer of the breast.
19722

About Mike Baum

Mike Baum is a scholar working on Oncology, Cancer Research, Genetics, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism, having authored 27 papers that have together received 2.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Estrogen and related hormone effects (5 papers), Global Cancer Incidence and Screening (3 papers), Cancer Risks and Factors (2 papers), Menopause: Health Impacts and Treatments (2 papers), BRCA gene mutations in cancer (2 papers), Cancer survivorship and care (2 papers) and Advances in Oncology and Radiotherapy (2 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.0k citations), Genetics (820 citations), Reproductive Medicine (80 citations) and Obstetrics and Gynecology (65 citations). Mike Baum has collaborated with scholars based in United Kingdom, Italy and Canada. Frequent co-authors include Lesley J. Fallowfield, Roger A’Hern, J. Houghton, Nigel P. M. Sacks, NPM Sacks, Jo Marsden, Malcolm Whitehead, Jane B. Davey, T.J. Powles and Mary E.R. O'Brien. Their work appears in journals such as European Journal of Cancer, British Journal of Cancer, Fertility and Sterility, Journal of the Royal Society of Medicine and European Journal of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact